- Title
- Results from a phase I study of continuous infusion cladribine, high-dose cytarabine, and mitoxantrone for relapsed/refractory high-grade myeloid neoplasms
- Creators - without role
- Noam E Kopmar - University of WashingtonTed Gooley - Fred Hutch Cancer CenterNiall Curley - University of WashingtonKathryn Russell - University of WashingtonCarole Shaw - Fred Hutch Cancer CenterKelda Schonhoff - University of WashingtonJohn Lim - University of WashingtonAnna B Halpern - University of WashingtonRoland B Walter - Fred Hutch Cancer CenterBart L Scott - University of WashingtonJacob Appelbaum - University of WashingtonPaul C Hendrie - University of WashingtonElihu H Estey - Fred Hutch Cancer CenterMary-Elizabeth M Percival - Fred Hutch Cancer CenterJie Sheng John Lim - EPD Pillar
- Publication Details
- Leukemia & lymphoma, Vol.64(5), pp.1057-1059
- Grant note
- T32 HL007093 / NHLBI NIH HHS P30 CA015704 / NCI NIH HHS
- Identifiers
- 9911617309846
- Academic Unit
- Engineering Product Development (EPD)
- Language
- English
- Resource Type
- Journal article
Journal article
Results from a phase I study of continuous infusion cladribine, high-dose cytarabine, and mitoxantrone for relapsed/refractory high-grade myeloid neoplasms
Leukemia & lymphoma, Vol.64(5), pp.1057-1059
05/2023
PMID: 36896478
Metrics
1 Record Views